Asset Details
Do you wish to reserve the book?
The Influence of CYP1A2 Genotype on Neuromuscular Function Following Acute Caffeine Administration
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Influence of CYP1A2 Genotype on Neuromuscular Function Following Acute Caffeine Administration
Do you wish to request the book?
The Influence of CYP1A2 Genotype on Neuromuscular Function Following Acute Caffeine Administration
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Dissertation
The Influence of CYP1A2 Genotype on Neuromuscular Function Following Acute Caffeine Administration
2019
Overview
The purpose of this study is to examine whether genetic variation in CYP1A2 (-163A>C, rs762551) influences the effects of acute caffeine supplementation on neuromuscular function of the lower body at rest and in response to a fatiguing work bout. Forty-two young, healthy males completed the entire study protocol and were genotyped for CYP1A2 enzyme. Subjects were then classified as AA (FAST: n = 26) or AC/CC (SLOW; n =16). This study consisted of 3 separate visits to the laboratory, a familiarization session and 2 experimental sessions: caffeine (CAF; 6 mg/kg/bw) or placebo (PLA). During each session, neuromuscular function, including motor unit behavior, muscle activation, spinal and supraspinal excitability, and muscle contractile properties were assessed. Additionally, each experimental visit ended with repeated, intermittent submaximal contractions at 50% of the subject’s maximum effort to fatigue. The main findings from this investigation were the overall lack of ergogenic effects of caffeine on neuromuscular function of the lower body musculature. Specifically, no significant alterations in motor unit behavior, muscle activation, or spinal or supraspinal excitability were found from pre- to post-testing in either condition. However, the present data suggest that caffeine may augment the decline seen in muscle contractile properties in the placebo condition. The present data also suggests a limited role, if any, for the CYP1A2 genotype in mediating the effects of caffeine on neuromuscular function.
